Australia, Sept. 2 -- Definium Therapeutics US Inc., owns the trademark (2661514) for 'PRECISE SCIENCE. BOUNDLESS IMPACT.' till April 17, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of su...